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ABSTRACT
Venous thromboembolism (VTE), deep vein thrombosis (DVT) and pulmonary embolism (PE) are uncommon after spine surgery. 
Increasing age, obesity and prolonged anaesthesia time are considered as high-risk factors for the occurrence of VTE in spinal surgeries. 
To prevent this fatal complication, many surgeons adopt mechanical prophylaxis like antiembolic stockinet, sequential pneumatic 
compression devices and early mobilization. Golden hour management of pulmonary embolism is of paramount importance. Even 
though PE are less commonly described in spinal surgeries, exercising caution on high-risk patients can prevent the catastrophic 
events. We are reporting a fatal case of pulmonary embolism following the degenerative lumbar spine surgery who succumbed to 
death despite the use of mechanical and pharmacologic prophylaxis (LMWH–Clexane-Enoxaparin Sodium).
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Venous thromboembolism (VTE), deep vein thrombosis (DVT) and pulmonary embolism (PE) are uncommon after spine surgery. Venous stasis, endothelial injury 
and the hypercoagulable state contribute to the postoperative 
development of VTE. Measures of prophylaxis are mechanical 
and or pharmacological. Most surgeons prefer anti-embolic 
stockings and sequential mechanical compression devices for 
preventing the DVT [1,2], but these measures prevent the lower 
limb VTE and not the pelvic VTE which is even more lethal. We 
routinely use anti-embolism stockings in the perioperative period, 
flowtran during the intraoperative and early postoperative period 
in all our patients with additional pharmacologic agents like low 
molecular weight heparin (LMWH) for high-risk patients. 
In this article, we report a case of fatal pulmonary embolism 
after spine surgery despite the usage of mechanical and 
pharmacologic prophylaxis.
CASE REPORT
A 64-year-old Sudanese patient admitted to the hospital with 
complaints of chronic low back pain, weakness of right knee and 
ankle for 4 weeks duration, difficulty in walking due to pain and 
weakness in both lower limbs. The patient was ambulant with 
support only to attend his nature calls, otherwise was bedridden. 
There was no history of bowel and bladder disturbances. The 
patient had a history of obstructive sleep apnoea and chronic 
obstructive pulmonary disease (COPD) with mild pulmonary 
artery hypertension. The patient had no other medical 
comorbidities. 
On examination, the patient was obese (172 cms/120 Kg; 
BMI 40.6) and the vitals were stable. The patient was found to 
have right side foot drop due to the weakness of ankle dorsiflexor 
which was 2/5, right knee flexors weakness which was 1/5 and 
left knee flexors weakness which was 4/5 in power. The sensation 
was less in the right foot dorsum and plantar aspects. 
Magnetic resonance imaging (MRI) revealed multilevel 
lumbar canal stenosis from L3 to L5 and retrolisthesis at L5-S1 
level. After a complete evaluation, pre-anaesthetic fitness was 
obtained. Venous Doppler of both lower limb was done which 
showed a normal study. 
The patient underwent posterior decompression L3 to S1 
level, transforaminal lumbar interbody fusion in L5-S1 level 
and posterolateral fusion in L3-L5 levels (Fig. 1). During 
decompression, there was a dural tear at L3-L4 level which was 
sutured with 4-0 prolene. After dural closure, Valsalva maneuver 
was done and no cerebrospinal fluid (CSF) leak was noted. Because 
of dural tear anaesthesia, time was prolonged. Wound closure was 
watertight with complete haemostasis and a thorough lavage with 
a superficial drain in situ. The patient was in bed rest for two days 
then mobilised with support. The patient developed left ankle 
weakness after surgery, hence mobilization schedule was slow. 
Considering patient age and obesity, we started LMWH (clexane 
0.6ml sc) 12 hours prior to surgery and continued to 12 hours 
after the surgery and extended to once daily in the postoperative 
period. The patient was also on mechanical prophylaxis for DVT 
in the lower limbs like flowtron for first two days and anti-embolic 
stockings in the next two days. The surgical wound was cleaned 
and the drain was removed on the second postoperative day. 
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The patient was made to stand with gutter walker support after 
two days and frequent bed to chair mobilization was done. Passive 
movements of both lower limbs were exercised at an hourly 
interval with frequent turning in the bed. The patient was under 
regular chest physiotherapy with incentive spirometry exercises. 
The patient was asymptomatic till the fifth postoperative day. 
On the sixth postoperative day, the patient developed breathing 
difficulty and became unconscious, so shifted to the intensive 
care unit, intubated, pulse rate dropped to 40 per minute and 
blood pressure was found to be non-recordable. Inotropes were 
started and blood pressure was raised to 86/30 mmHg but the 
patient was not arousable.
Echocardiography (ECHO) was done which showed dilated 
right atrium, right ventricle, and main pulmonary artery. Mild 
tricuspid regurgitation, severe right ventricle dysfunction, global 
hypokinesia of left ventricle, bradykinin study, ejection fraction 
20%, and inferior vena cava dilated to 22mm and no respiratory 
collapse. ECHO was suggestive of massive pulmonary embolism 
and was planned for thrombolysis, but the patient developed 
pulseless electrical activity, so Cardio-Pulmonary Resuscitation 
(CPR) was started and continued for 40 minutes but the patient 
could not be revived.
DISCUSSION
Pharmacologic prophylaxis agents used for reducing the 
incidence of VTE is well-established in arthroplasty and trauma 
patients [3] but in spine surgery, there is no consensus on using 
pharmacologic agents like Low dose unfractionated heparin 
(LDUH) or LMWH for reducing VTE, due to possible risk of 
developing an epidural haematoma which can compress the 
neural structures and can lead to permanent neurological deficit 
like paralysis [4]. Many surgeons prefer to use only mechanical 
prophylaxis like anti-embolism stockings and sequential 
compression device (flowtran) [1,2]. Inferior vena cava (IVC) 
filter is commonly used in the patient who had previous history 
DVT or PE and routine use of IVC filter for DVT prevention in 
spine surgery is not recommended [5].
Incidence of VTE after spine surgery is low as compared with 
arthroplasty and trauma patients. In the literature, VTE incidences 
were reported as low as 0.29% up to 23.4% after spine surgery 
[6,7,8.] Incidences of symptomatic VTE and asymptomatic VTE 
were different.  Takahashi et al conducted a study on 100 patients 
after spine surgery and reported that asymptomatic PE in 18% of 
the patients and DVT in 19% of the patients [9]. Hohl et al [10] 
reported in his multi-institutional study that symptomatic VTE 
after spine surgery accounts for 1.5%, symptomatic PE accounts 
for 0.88% and DVT accounts for 0.66% of the patients. Lingde 
et al in his meta-analysis reported incidences of DVT and PE as 
1.22% and 0.45% [11].
In spine surgery, the incidence of VTE is more in lumbar 
or thoracolumbar surgeries as compared with cervical spine 
surgeries [12]. Schizas et al [13] suggested the use of LMWH 
for preventing VTE as an acceptable option since symptomatic 
PE with LMWH was 2.2% and the risk of epidural haematoma 
formation with LMWH was only 0.7%. Jia Qi Li et al [4] in 
his meta-analysis reported symptomatic DVT to be 1.09%, 
symptomatic PE as 0.06% and recommended only mechanical 
prophylaxis after spine surgery to avoid epidural haematoma by 
the pharmacologic agents. Masuda k et al [14] quoted in his study 
the incidence of 0.10% PE in 47743 patients and reported the 
death in four patients. 
In the case of symptomatic PE, temporary IVCF should 
be inserted within 7 days of surgery to avoid postoperative 
haematoma formation by giving full anti-coagulant therapy. Full 
anticoagulation therapy can be initiated after temporary IVCF 
removal and in case of symptomatic PE after 8 days of surgery; 
full coagulation therapy can be started even though the 8th day is 
arbitrary for anti-coagulation therapy [13]. Following factors are 
considered as high-risk factors for developing VTE after elective 
Figure 1: Multilevel lumbar canal stenosis treated by posterior decompression and fusion.
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spine surgery: increasing age, obesity, prolonged anaesthesia 
time, previous history of DVT and PE, high D Timer value, 
preoperative walking ability [3,11,14,15].
CONCLUSION
Venous thromboembolic events are not common after spine 
surgery but well noted in the literature. The efficacy of 
pharmacologic agents to lower the incidence of VTE in post-
spine surgery is uncertain. Without randomized controlled trials, 
routine use of LMWH in post-spine surgery is debatable. Though 
symptomatic PE is very low after spine surgery, it is better to be 
expectant and cautious in high-risk patients.  
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